These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 210235)

  • 41. Inotropic responses to selective (RO 20-1724 and SQ 65,442) and nonselective (trequinsin) inhibitors of cyclic AMP-specific class IV phosphodiesterase in newborn, immature, and adult rabbit myocardium.
    Oquist NL; Strada SJ; Artman M
    Pediatr Res; 1992 Mar; 31(3):300-4. PubMed ID: 1313959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activities of 3':5' cyclic nucleotide phosphodiesterases in the superior cervical ganglion of rat: characterization, compartmentalization and observations in young and old animals.
    Giorgi M; Squitti R; Bonsi P; Paggi P; Toschi G
    Neurochem Int; 1994 Nov; 25(5):493-500. PubMed ID: 7849578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. On the mechanism of relaxation of tracheal muscle by theophylline and other cyclic nucleotide phosphodiesterase inhibitors.
    Fredholm BB; Brodin K; Strandberg K
    Acta Pharmacol Toxicol (Copenh); 1979 Nov; 45(5):336-44. PubMed ID: 231892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of cyclic AMP in differentiation of human neuroblastoma cells in culture.
    Prasad KN; Kumar S
    Cancer; 1975 Oct; 36(4):1338-43. PubMed ID: 240503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 1-(4-Aminobenzyl)-and 1-(4-aminophenyl)isoquinoline derivatives: synthesis and evaluation as potential irreversible cyclic nucleotide phosphodiesterase inhibitors.
    Walker KA; Boots MR; Stubbins JF; Rogers ME; Davis CW
    J Med Chem; 1983 Feb; 26(2):174-81. PubMed ID: 6298424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective inhibition of two soluble adenosine cyclic 3',5'-phosphate phosphodiesterases partially purified from calf liver.
    Yamamoto T; Lieberman F; Osborne JC; Manganiello VC; Vaughan M; Hidaka H
    Biochemistry; 1984 Feb; 23(4):670-5. PubMed ID: 6324851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships.
    Van Inwegen RG; Salaman P; St Georgiev V; Weinryb I
    Biochem Pharmacol; 1979 Apr; 28(8):1307-12. PubMed ID: 87199
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
    Kuo JF; Shoji M; Brackett NL; Helfman DM
    J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel compounds possessing potent cAMP and cGMP phosphodiesterase inhibitory activity. Synthesis and cardiovascular effects of a series of imidazo[1,2-a]quinoxalinones and imidazo[1,5-a]quinoxalinones and their aza analogues.
    Davey DD; Erhardt PW; Cantor EH; Greenberg SS; Ingebretsen WR; Wiggins J
    J Med Chem; 1991 Sep; 34(9):2671-7. PubMed ID: 1654425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE; Lakey T; Houslay MD
    Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The metabolism of cyclic nucleotides in the guinea-pig pancreas. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase.
    Methven P; Lemon M; Bhoola K
    Biochem J; 1980 Feb; 186(2):491-8. PubMed ID: 6246887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of theophylline and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO 20-1724) on protein secretion from rat parotid gland.
    Afari G; Tenenhouse A; Vachon C
    Br J Pharmacol; 1982 Nov; 77(3):405-11. PubMed ID: 6291691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells.
    Shimizu E; Kobayashi Y; Oki Y; Kawasaki T; Yoshimi T; Nakamura H
    Life Sci; 1999; 64(23):2081-8. PubMed ID: 10372650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 1-(4-Aminophenyl)isoquinoline derivatives. Potent inhibitors of calcium-independent and calcium-dependent phosphodiesterases from rat cerebral cortex.
    Davis CW; Walker KA
    Biochem Pharmacol; 1984 Apr; 33(8):1205-12. PubMed ID: 6324818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclic nucleotide-phosphodiesterase in the uninvolved and involved skin of psoriasis.
    Iizuka H; Adachi K; Halprin KM; Levine V
    J Invest Dermatol; 1978 May; 70(5):246-9. PubMed ID: 205615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
    Muggli R; Tschopp TB; Mittelholzer E; Baumgartner HR
    J Pharmacol Exp Ther; 1985 Oct; 235(1):212-9. PubMed ID: 2995647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
    Bellamy TC; Garthwaite J
    Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclic GMP metabolism in psoriasis: increased activity of soluble epidermal cyclic GMP phosphodiesterase and its modulation by calcium.
    Cantieri JS; Graff G; Goldberg ND
    Br J Dermatol; 1981 Mar; 104(3):301-5. PubMed ID: 6260127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.